Choate represented Watchmaker Genomics, Inc. in obtaining the dismissal of a patent infringement complaint filed against the company by biomodal Limited and Children’s Medical Center Corporation in the U.S. District Court for the District of Colorado. In biomodal Limited and Children’s Medical Center Corporation v. Watchmaker Genomics, Inc., No. 1:25-cv-03646-RMR-KAS (D. Colo.), the plaintiffs alleged that Watchmaker’s TAPS+ product infringed U.S. Patent Nos. 12,018,320 and 12,291,742 and sought damages and injunctive relief. On September 30, 2026, the Court overruled the plaintiffs’ objections, adopted the Report and Recommendation of U.S. Magistrate Judge Kathryn Starnella, and granted Watchmaker’s motion to dismiss. The Court agreed that the asserted claims are directed to patent-ineligible subject matter under 35 U.S.C. § 101 because they rely on a naturally occurring process without sufficient additional steps to make that process patentable. The Court dismissed the complaint without prejudice, entered final judgment in Watchmaker’s favor, and closed the case. Watchmaker Genomics is a developer and manufacturer of precision reagents for genomics and molecular diagnostics. Its DNA Library Prep Kit with TAPS+ uses bisulfite-free chemistry to enable simultaneous detection of DNA methylation and genetic variants from a single library. The Choate team was led by Michael Bunis, with additional support from Bryana McGillycuddy, Madison Garrett, and Maria Martinez. For more information, please see Watchmaker’s announcement.